Compositions and methods for treating, preventing, or ameliorating one or more symptoms, conditions, or disorders associated with coronavirus infections are provided, in particular small-molecule inhibitors of the chymotrypsin-like cysteine protease of SARS CoV.
US4025505A
申请人:——
公开号:US4025505A
公开(公告)日:1977-05-24
Aromatic dicarboxamides
申请人:Ciba-Geigy Corporation
公开号:US04025505A1
公开(公告)日:1977-05-24
N-(4-aminophenyl)-aromatic dicarboximides, e.g. those of the formula ##STR1## OR SALTS THEREOF ARE ANTICONVULSANTS.